Tania Jain

Also affiliated with Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.544Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis

British Journal of Haematology(2024)10.1111/bjh.19569

Top 36%

0.544DataRank

Top 36%12 citations

Hamza Hashmi, Kwang Woo Ahn, Mariam Allbee‐Johnson, Andy I. Chen, Baldeep Wirk +12 more

Papers

Driven by 25 papers — median percentile 64. Top paper: “Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation”.

Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

Journal of Clinical Investigation(2020)10.1172/jci141777

N/A

0.725DataRank · unranked

125 citations

Susan DeWolf, Yeon Joo Lee, Roni Tamari, Parastoo B. Dahi, Jessica A. Lavery +23 more

Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.02.012

N/A

0.700DataRank · unranked

105 citations

Tania Jain, Junting Zheng, Molly Maloy, Josel D. Ruiz, Martina Pennisi +4 more

Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.07.018

N/A

0.677DataRank · unranked

90 citations

Tania Jain, M. Veronica Dioverti, Martina Pennisi, Lekha Mikkilineni, Swetha Kambhampati Thiruvengadam +9 more

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis

British Journal of Haematology(2024)10.1111/bjh.19569

Top 36%

0.544DataRank

Top 36%12 citations

Hamza Hashmi, Kwang Woo Ahn, Mariam Allbee‐Johnson, Andy I. Chen, Baldeep Wirk +12 more

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Blood Advances(2020)10.1182/bloodadvances.2019001266

N/A

0.542DataRank · unranked

36 citations

Rajneesh Nath, Jan Černý, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel‐Azim +80 more

Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel

British Journal of Haematology(2022)10.1111/bjh.18454

N/A

0.489DataRank · unranked

25 citations

Ana Lazarevic, Jamie E. Ziggas, Ephraim J. Fuchs, Kiryoung Kim, Helen Byrnes +7 more

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Blood Advances(2023)10.1182/bloodadvances.2023009886

N/A

0.464DataRank · unranked

21 citations

Donal P. McLornan, Kwang Woo Ahn, Noel Estrada‐Merly, Juan Carlos Hernández‐Boluda, Sergio Giralt +46 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0.335DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more

Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.10.022

N/A

0DataRank · unranked

42 citations

Binod Dhakal, Tania Jain, Olalekan O. Oluwole, Gunjan L. Shah, Surbhi Sidana +3 more

Characterization of myeloproliferative neoplasms in the paediatric and young adult population

British Journal of Haematology(2023)10.1111/bjh.18650

N/A

0DataRank · unranked

20 citations

Hannah Kaizer, Aria Wei, Theodoros Karantanos, Donna M. Williams, Shruti Chaturvedi +5 more

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration

Haematologica(2023)10.3324/haematol.2023.283426

N/A

0DataRank · unranked

13 citations

Hua‐Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah Wall +18 more

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

Research Square(2023)10.21203/rs.3.rs-2802265/v1

N/A

0DataRank · unranked

2 citations

Jonathan P. Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Riley E. Bergman +15 more

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Blood Advances(2024)10.1182/bloodadvances.2024013451

N/A

0DataRank · unranked

14 citations

Noel Estrada‐Merly, María Queralt Salas, Soyoung Kim, Jakob D. DeVos, Min Chen +59 more

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

Blood Advances(2024)10.1182/bloodadvances.2023011260

N/A

0DataRank · unranked

8 citations

Jonathan P. Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Panagiotis Tsakiroglou +19 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Blood Advances(2025)10.1182/bloodadvances.2025016141

N/A

0DataRank · unranked

15 citations

Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda +32 more

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

Leukemia Research(2025)10.1016/j.leukres.2025.108098

N/A

0DataRank · unranked

1 citations

Daniel Li, Hua‐Ling Tsai, Gabriel Ghiaur, B. Douglas Smith, Mark J. Levis +10 more

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945

N/A

0DataRank · unranked

31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more

Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.09.022

N/A

0DataRank · unranked

6 citations

Matthew L. Smith, Hua‐Ling Tsai, Ravi Varadhan, Amy E. DeZern, W. Brian Dalton +23 more

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.02.004

N/A

0DataRank · unranked

27 citations

Hua‐Ling Tsai, Amy E. DeZern, Lukasz P. Gondek, Hany Elmariah, Javier Bolaños‐Meade +22 more

Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.015

N/A

0DataRank · unranked

19 citations

Armin Ghobadi, John F. Dipersio, Brian T. Hill, M. Shadman, Tania Jain +1 more

Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.009

N/A

0DataRank · unranked

11 citations

Michael Sang Hughes, Hua‐Ling Tsai, Kathryn Yarkony, Ephraim J. Fuchs, Lode J. Swinnen +15 more

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018

N/A

0DataRank · unranked

7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Tania Jain

Indexed papers

Top data-sharing exemplar

Papers